🔗 Share this article

The prestigious award in medical science was awarded for revolutionary discoveries that clarify how the immune system attacks dangerous pathogens while sparing the healthy tissues.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this honor.

The work identified unique "sentinels" within the immune system that remove malfunctioning defense cells capable of harming the body.

These findings are now paving the way for innovative therapies for immune disorders and malignancies.

The winners will share a prize fund worth 11 million Swedish kronor.

Crucial Findings

"The work has been essential for comprehending how the body's defenses operates and the reason we don't all suffer from serious autoimmune diseases," commented the chair of the award panel.

The trio's research explain a fundamental mystery: In what way does the immune system protect us from numerous infections while leaving our own tissues unharmed?

The body's protection system employs immune cells that scan for signs of infection, including pathogens and bacteria it has not met before.

These cells employ sensors—called recognition units—that are produced by chance in countless variations.

This provides the defense network the capacity to fight a broad range of threats, but the randomness of the process inevitably creates white blood cells that can attack the host.

Protectors of the Body

Scientists previously knew that some of these problematic defense cells were destroyed in the thymus—the site where immune cells mature.

The latest award honors the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the system to neutralize any defenders that attack the body's own tissues.

We know that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These discoveries have laid the foundation for a novel area of investigation and spurred the development of new treatments, for example for tumors and immune disorders."

Regarding malignancies, T-regs prevent the system from fighting the tumor, so studies are aimed at lowering their numbers.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the organism is no longer under attack. A similar approach could also be useful in reducing the risks of transplanted organ failure.

Innovative Studies

Prof Sakaguchi, of Osaka University, performed experiments on rodents that had their thymus extracted, leading to autoimmune disease.

The researcher showed that introducing defense cells from healthy mice could stop the illness—suggesting there was a mechanism for blocking defenders from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at a biotech firm in a California city, were studying an genetic autoimmune disease in rodents and humans that resulted in the identification of a gene critical for how regulatory T-cells operate.

"The groundbreaking work has revealed how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a leading physiology expert.

"The work is a striking illustration of how basic physiological study can have far-reaching implications for public health."